Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain
Details for Australian Patent Application No. 2002257680 (hide)
International Classifications
Event Publications
27 March 2003 Application Open to Public Inspection
Published as AU-B-2002257680
14 December 2006 Application Accepted
Published as AU-B-2002257680
19 April 2007 Standard Patent Sealed
10 June 2010 Alteration of Name
The name of the patentee has been altered to UCB Pharma GmbH
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002257681-Novel use of a peptide class of compound for treating non neuropathic inflammatory pain
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser